Skip to main content

Table 2 Effect of 0.9% isotonic saline (0.9% NaCl), 3% hypertonic saline (3% NaCl) and isotonic glucose (Glucose) on urinary output (OU), free water clearence (C H2O ), urine osmolarity (u-osm), urinary aquaporin2 excretion rate (u-AQP2) and urinary aquaporin2 corrected for creatinine (u-AQP2 CR ) in a randomized, crossover study of 23 healthy subjects

From: Effect of volume expansion with hypertonic- and isotonic saline and isotonic glucose on sodium and water transport in the principal cells in the kidney

Periods

Baseline

Infusion

Post infusion

p (GLM-within)

0-90 min

90-150 min

150-180 min

180-210 min

210-240 min

UO (ml/min)

0.9% NaCl

6.90(1.33)

8.75(1.76)

7.95(2.31)

7.39(2.36)

8.12(2.26)

<0.0001

3% NaCl

7.12(1.35)

2.75(0.73)

1.81(0.64)

1.98(1.07)

2.05(1.09)**

Glucose

6.83(1.58)

11.84(2.28)

16.05(2.82)

15.28(2.47)

13.45(2.47)**

p (GLM between)

 

<0.0001

    

p ANOVA

0.77

<0.0001

<0.0001

<0.0001

<0.0001

 

C H2O

0.9% NaCl

3.87(1.55)

5.29(1.44)

4.07(2.09)

3.01(2.04)

3.62(1.59)

<0.0001

3% NaCl

3.97(1.21)

-0.35(0.73)

-1.87(0.83)

-2.22(0.88)

-2.26(0.96)

Glucose

3.84(1.32)

6.38(1.77)

11.60(0.52)

12.47(2.35)

11.17(2.12)

p (GLM between)

 

<0.0001

    

p ANOVA

0.95

<0.0001

<0.0001

<0.0001

<0.0001

 

U- osm (mosmol/kg)

0.9% NaCl

140(62)

115(21)

149(58)

176(50)

161(33)

<0.0001

3% NaCl

136(37)

342(96)

606(114)

637(105)

640(111)*

Glucose

136(41)

133(21)

79(21)

52(12)

48(7)*

p (GLM between)

 

p <0.0001

    

p ANOVA

0.95

<0.0001

<0.0001

<0.0001

<0.0001

 

u-AQP2 (ng/min)

0.9% NaCl

1.03 (0.25)

1.02(0.22)

1.22(0.34)

-

1.26(0.32)*

<0.0001

3% NaCl

1.02(0.22)

0.99(0.31)

1.28(0.30)

-

1.37(0.34)*

Glucose

1.01(0.22)

1.26(0.25)

1.19(0.29)

-

0.78(0.18)*

p (GLM between)

 

0.274

    

u-AQP2 CR (ng/mmol)

0.9% NaCl

102.5(19.9)

110.8(18.1)

119.8(25.4)

-

125.0(21.0)**

<0.0001

3% NaCl

105.9(15.7)

108.6(27.2)

125.1(31.4)

-

132.7(26.5)*

Glucose

105.7(19.1)

137.1(22.3)

118.1(26.5)

-

87.9(15.4)*

p (GLM between)

 

0.565

    
  1. Values are mean with SD in brackets. General linear model (GLM) with repeated measures was performed for comparison within the group and intervention as between subjects factor. One way ANOVA was performed when differences were found between interventions. Paired t-test was used for comparison within treatment group at baseline and post infusion period 210 – 240 minutes. *p < 0.0001; **p < 0.001.